The global herpes labialis treatment market is estimated to be valued at USD 1,238.7 million in 2025 and is projected to reach USD 1,887.1 million by 2035, registering a CAGR of 4.3% over the forecast ...

In the world of viral research, uncovering a virus’s weaknesses is often a painstaking process that requires years of ...

Researchers discovered that HSV-1 (herpes simplex virus) actively reshapes the 3D layout of human DNA within hours of ...

Cold sore-causing HSV-1 doesn't just hijack cells it reconfigures the entire architecture of our DNA to aid its invasion.

Researchers have discovered that the herpes virus reshapes the human genome’s architecture, rearranging its shape in ...

Researchers in Spain may have found the first potential treatment that stops an incurable virus found in 122million Americans from spreading inside the body, according to a new study.

Can you cure cold sores? While individual cold sore episodes will heal, there’s no way to banish the virus from your body, so you’ll always be at risk for future outbreaks, Dr. Wassef said.

Especially for immunocompromised people, the virus can be debilitating. Of course, there are antivirals to treat the disease, the most common being acyclovir—but the treatments are not a cure. Once a ...

Two types of herpes HSV exists in two primary forms, each affecting different areas of the body. HSV-1 is commonly associated with oral infections, causing cold sores around the mouth and lips.

HSV-1 is less common as the source of genital herpes and typically shows up as oral herpes – mouth sores. HSV-2 is responsible for 90% of genital herpes episodes and is known to flare up over ...

HSV, or genital herpes, has affected millions of people around the world. Researchers and experts weigh in on the risks and developing treatments of the high-burden sexually transmitted infection.

This means about 13.3% of people in this age range had HSV-2. For genital HSV-1, there were 16.8 million new infections and 376.2 million people already living with it, equaling about 10.2% prevalence ...